Alzheimer’s & You: prevention & treatment of dementia

Despite many promising leads, no drug has yet been found to slow or modify the debilitating, and ultimately fatal, progress of Alzheimer’s disease, the most common form of dementia. Within 20 years almost half a million Australians will suffer from dementia, by 2050 the number will double to one million.

Is it realistic, then, to aspire to the holy grail of an Alzheimer’s free world?

And what if there is no cure to be had? How will Australia and the world – with some 113 million cases worldwide by 2050 – cope with the burden the disease imposes on sufferers, their families, health systems and national economies? And, what role might alternative non-drug interventions play in preventing or delaying the onset of the disease?

Two of Australia’s leading experts on dementia, Professor Henry Brodaty, from the University of New South Wales and Professor Nicola Lautenschlager, from the University of Melbourne, will join the President of Alzheimer’s Australia, Ita Buttrose, to answer these questions at a free public forum to mark World Alzheimer’s Day, Wednesday 21st September.

 

“The promise of cure has been a tantalising five years away for over 15 years,” says Professor Brodaty, Director of UNSW’s Dementia Collaborative Research Centre. “Unfortunately there’s been no magic bullet.”

While drug research continues, new findings are revealing other ways to protect against Alzheimer’s disease. Professor Lautenschlager – a world expert on diagnosis of cognitive impairment and intervention trials – will outline the latest research on the power of physical exercise and keeping mentally active to protect against cognitive decline.

What:  Alzheimer’s & You – free public seminar

When: 6-7.30pm, Wednesday 21 September 2011

Where: Wesley Conference Centre, 220 Pitt St, Sydney (btwn Market and Park Streets)

 

RSVP: [email protected]  (02) 9385 2585 or 9385 2702

 

Source: www.unsw.edu.au

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Common cardiovascular drugs linked to lower risk of dementia